logo

For the Inventor, By the Inventor

Osaka, Japan

Hirosada Sugihara

USPTO Granted Patents = 31

Average Co-Inventor Count = 3.1

ph-index = 8

Forward Citations = 224(Granted Patents)


Location History:

  • Suita, JA (1976)
  • Osaka, JA (1977)
  • Osaka, JP (1978 - 1991)
  • Mishima, JP (1994)
  • Tsukuba, JP (1996)

Company Filing History:

goldMedal31 out of 1,858 
 
Takeda Chemical Industries, Inc.
 patents

Years Active: 1976-1996

Loading Chart...
31 patents (USPTO):Explore Patents
1. 5550131 - 2-piperazinone compounds and their use (1996-08-27),
2. 5294713 - 2-piperazinone compounds and their use (1994-03-15),
3. 4997836 - Trisubstituted piperazine compounds, their production and use (1991-03-05),
4. 4954625 - Piperidine derivatives, their production and use (1990-09-04),
5. 4937246 - PAF antagonist, 1,4-disubstituted piperazine compounds and production (1990-06-26),
6. 4880809 - 1,4-disubstituted piperazines (or homopiperazines) as (1989-11-14),
7. 4871842 - Piperidine derivatives (1989-10-03),
8. 4816466 - Piperidine derivatives (1989-03-28),
9. 4751316 - 1,5-benzoxathiepin derivatives (1988-06-14),
10. 4739066 - Intermediates for the preparation of condensed seven-membered ring (1988-04-19),
11. 4736031 - 2-(piperazinylalkyl)-1-benzothiepin, 1-benzoxepin, and 1,5-benzodioxepin (1988-04-05),
12. 4672064 - 1,5-benzoxathiepin derivatives, their production and use (1987-06-09),
13. 4638000 - Condensed seven-membered ring compounds, their production and use (1987-01-20),
14. 4591458 - 3-amino-4-oxo-2,3,4,5-tetrahydro-1,5-benzoxazepine derivatives (1986-05-27),
15. 4564612 - Condensed, seven-membered ring compounds and their use (1986-01-14),

Title: The Inventor Profile: Hirosada Sugihara from Osaka

Introduction: Hirosada Sugihara, a prolific inventor based in Osaka, Japan, is making significant strides in the field of pharmaceuticals with a collection of 31 patents to his name. His innovative work at Takeda Chemical Industries, Inc. showcases his dedication to developing cutting-edge solutions for various medical needs.

Latest Patents: Among his latest patents is the groundbreaking work on 2-piperazinone compounds and their use. These compounds exhibit potent and long-lasting activities in inhibiting cell-adhesion, thus serving as valuable orally administrable anti-thrombotic agents. The compounds offer promise in prophylaxis and therapy for a range of diseases by effectively controlling or inhibiting cell adhesion.

Career Highlights: Hirosada Sugihara's career at Takeda Chemical Industries, Inc. has been marked by a relentless pursuit of innovation in the pharmaceutical realm. With a keen focus on developing novel compounds and pharmaceutical agents, his work is poised to revolutionize the treatment landscape for various medical conditions.

Collaborations: Sugihara's collaborations with esteemed coworkers such as Kohei Nishikawa and Katsumi Ito have been instrumental in bringing his inventive ideas to fruition. Together, they form a dynamic team at Takeda Chemical Industries, Inc., driving forward progress in the development of groundbreaking pharmaceutical solutions.

Conclusion: In conclusion, Hirosada Sugihara stands as a pioneering inventor whose dedication to advancing pharmaceutical science is truly commendable. Through his trailblazing work on innovative compounds and pharmaceutical agents, Sugihara is shaping the future of medical treatment, offering hope for improved therapeutic outcomes and enhanced patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…